Intention-to-treat meets missing data: implications of alternate strategies for analyzing clinical trials data.

[1]  J. Fawcett,et al.  Clinical management--imipramine/placebo administration manual. NIMH Treatment of Depression Collaborative Research Program. , 1987, Psychopharmacology bulletin.

[2]  Anthony S. Bryk,et al.  Application of Hierarchical Linear Models to Assessing Change , 1987 .

[3]  D. Hedeker,et al.  Random regression models: a comprehensive approach to the analysis of longitudinal psychiatric data. , 1988, Psychopharmacology bulletin.

[4]  K. Howard,et al.  Attrition in substance abuse comparative treatment research: the illusion of randomization. , 1990, NIDA research monograph.

[5]  Joyce A. Cramer,et al.  Patient Compliance in Medical Practice and Clinical Trials , 1991 .

[6]  J H Ellenberg,et al.  Analysis of clinical trials by treatment actually received: is it really an option? , 1991, Statistics in medicine.

[7]  M. Schuckit,et al.  The anatomy of a follow-up. , 1992, British journal of addiction.

[8]  P W Lavori,et al.  Clinical trials in psychiatry: should protocol deviation censor patient data? , 1992, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[9]  S D Imber,et al.  Some conceptual and statistical issues in analysis of longitudinal psychiatric data. Application to the NIMH treatment of Depression Collaborative Research Program dataset. , 1993, Archives of general psychiatry.

[10]  R. J. Hayes,et al.  Blinding and exclusions after allocation in randomised controlled trials: survey of published parallel group trials in obstetrics and gynaecology , 1996, BMJ.

[11]  I. Olkin,et al.  Improving the quality of reporting of randomized controlled trials. The CONSORT statement. , 1996, JAMA.

[12]  F. D. Del Boca,et al.  Assessment of medication compliance in alcoholics through UV light detection of a riboflavin tracer. , 1996, Alcoholism, clinical and experimental research.

[13]  W. Compton,et al.  Achieving a 96.6 percent follow-up rate in a longitudinal study of drug abusers. , 1996, Drug and alcohol dependence.

[14]  A. Edwards,et al.  Outcome studies of brief alcohol intervention in general practice: the problem of lost subjects. , 1997, Addiction.

[15]  F. D. Del Boca,et al.  Compliance with treatment and follow-up protocols in project MATCH: predictors and relationship to outcome. , 1998, Alcoholism, clinical and experimental research.

[16]  K. Carroll,et al.  Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram. , 1998, Addiction.

[17]  B. Crawley,et al.  Reporting of randomized clinical trial descriptors and use of structured abstracts. , 1998, JAMA.

[18]  C. Meinert Beyond CONSORT: need for improved reporting standards for clinical trials. Consolidated Standards of Reporting Trials. , 1998, JAMA.

[19]  P. Lavori,et al.  Plans, designs, and analyses for clinical trials of anti-cocaine medications: where we are today. NIDA/VA/SU Working Group on Design and Analysis. , 1999, Journal of clinical psychopharmacology.

[20]  S. Hollis,et al.  What is meant by intention to treat analysis? Survey of published randomised controlled trials , 1999, BMJ.

[21]  B. Kupelnick,et al.  Effectiveness of antidepressants , 1999, British Journal of Psychiatry.

[22]  M. Martínez-González,et al.  Intention to treat analysis is related to methodological quality , 2000, BMJ : British Medical Journal.

[23]  B. Rounsaville,et al.  A general system for evaluating therapist adherence and competence in psychotherapy research in the addictions. , 2000, Drug and alcohol dependence.

[24]  Patrick E. McKnight,et al.  Multivariate modeling of missing data within and across assessment waves. , 2000, Addiction.

[25]  H. Williams,et al.  How well are randomized controlled trials reported in the dermatology literature? , 2000, Archives of dermatology.

[26]  D. Moher,et al.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. , 2001, Journal of the American Podiatric Medical Association.

[27]  Alvan R. Feinstein,et al.  Principles of Medical Statistics , 2001 .

[28]  D. Moher,et al.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials , 2001, The Lancet.

[29]  A. Blaszczynski,et al.  Dropouts in clinical research: Do results reported reflect clinical reality? , 2001 .

[30]  D Moher,et al.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. , 2001, Annals of internal medicine.

[31]  Paul D. Bliese,et al.  Book Review: Modeling Longitudinal and Multilevel Data: Practical Issues, Applied Approaches, and Specific Examples, edited by T. D. Little, K. U. Schnabel, and J. Baumert (2000). Mahwah, Nj: Lawrence Erlbaum. , 2003 .